Increasing use of MIGS in clinical practice reflects how glaucoma care is evolving. If you are managing the condition, you may benefit from having more treatment options earlier in the disease pathway. Over time, this approach may help improve outcomes while reducing the need for more invasive surgery later on.<\/p>\n
Types of MIGS Procedures<\/h2>\n
There are several types of MIGS procedures available, each designed to target different drainage pathways in your eye. You may be offered trabecular, suprachoroidal, or subconjunctival approaches depending on your specific condition. These options allow surgeons to tailor treatment more precisely to your needs.<\/p>\n
Each technique works in a slightly different way to improve the outflow of fluid and reduce intraocular pressure. You may benefit from a procedure that is selected based on how your eye drains fluid and how advanced your glaucoma is. This personalised approach helps improve surgical effectiveness for you.<\/p>\n
The choice of procedure depends on your individual patient factors and overall treatment goals. You may find that ongoing research continues to refine these techniques for better safety and outcomes. Overall, MIGS options are expanding to offer more targeted and effective treatment choices for you.<\/p>\n
MIGS Devices and Innovation<\/h2>\n
A wide range of MIGS devices has been developed in recent years to improve glaucoma surgery outcomes for you. You may benefit from devices designed to increase precision while reducing surgical trauma to the eye. These innovations aim to make the procedure safer and more controlled.<\/p>\n
Newer generations of MIGS devices focus on improving durability and long-term performance. You may find that advancements in design help maintain more consistent pressure control over time. Researchers are continuously working to refine these devices to improve reliability for patients like you.<\/p>\n
Innovation in device design remains a key area of research in glaucoma care. You may see ongoing improvements that enhance both safety and effectiveness of treatment. Overall, these developments continue to drive better surgical outcomes for you in modern MIGS procedures.<\/p>\n
Combination with Cataract Surgery<\/h2>\n
MIGS is often performed alongside cataract surgery to treat both conditions at the same time. You may benefit from this combined approach, as it allows the surgeon to address lens opacity and elevated intraocular pressure in a single procedure. This can make treatment more efficient and streamlined for you.<\/p>\n
This dual approach means you may achieve improved vision from cataract removal while also gaining better pressure control from MIGS. You may find it more convenient to undergo one surgery rather than two separate procedures. Recovery time is often similar to cataract surgery alone, which can make the overall process easier for you.<\/p>\n
This combination is widely used in clinical practice due to its practical benefits and good patient outcomes. You may be considered for this approach depending on your eye health and disease severity. Overall, it offers a balanced way to manage both cataract and glaucoma together for you.<\/p>\n
Patient Selection Criteria<\/h2>\n
![\"\"](\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/03\/images-12.jpg\")
<\/p>\n
If you are being considered for minimally invasive glaucoma surgery (MIGS), it is important for you to know that not every glaucoma patient is automatically suitable for this type of procedure. Careful assessment is always carried out by your eye specialist to determine whether MIGS is appropriate for your specific condition. Factors such as the severity of your glaucoma, the structure of your eye, and any previous treatments you have had all play a role in this decision. This ensures that the chosen treatment is safe and effective for you.<\/p>\n
- \n
- Careful Assessment Is Needed for You: <\/strong>If MIGS is being considered, your specialist will evaluate your overall eye health in detail. This helps ensure the procedure is suitable for your individual condition.<\/li>\n
- Disease Severity Matters for Your Treatment: <\/strong>If your glaucoma is in the early to moderate stages, you may be more likely to benefit from MIGS. More advanced disease may require different surgical approaches.<\/li>\n
- Your Eye Anatomy Is an Important Factor: <\/strong>If the structure of your eye is not suitable, MIGS may not be the best option for you. Detailed imaging and examination help guide this decision.<\/li>\n
- Previous Treatments Influence Your Options: <\/strong>If you have already undergone certain treatments or surgeries, this may affect whether MIGS is appropriate. Your treatment history is always taken into account.<\/li>\n
- Best Outcomes Depend on Proper Selection for You: <\/strong>If the right patients are selected, MIGS can provide effective pressure control and good outcomes. Careful matching of procedure and patient is key to success.<\/li>\n<\/ul>\n
Patient selection is a critical part of ensuring safe and effective MIGS outcomes. If you are being evaluated, your specialist will consider multiple factors to decide whether this approach is right for you. With proper selection, MIGS can be a valuable part of your glaucoma treatment pathway and may help you achieve better long-term eye pressure control.<\/p>\n
Safety Profile of MIGS<\/h2>\n
One of the key advantages of MIGS is its favourable safety profile for you. You may find that compared to traditional glaucoma surgery, it generally involves fewer complications and a more controlled recovery process. This makes it a preferred option for many suitable patients.<\/p>\n
However, like all surgical procedures, certain risks still exist. You may experience temporary side effects such as inflammation or short-term fluctuations in intraocular pressure after the procedure. These effects are usually monitored closely and managed by your specialist.<\/p>\n
Overall, MIGS is considered a safer surgical option for appropriate candidates. You may benefit from its minimally invasive nature, which helps reduce surgical trauma while still effectively managing your glaucoma. This balance of safety and effectiveness makes it an important advancement in modern eye care.<\/p>\n
Recovery After MIGS<\/h2>\n
Recovery after MIGS is usually quicker compared to more invasive glaucoma surgeries. You may experience mild discomfort or irritation for a short period following the procedure. These symptoms are generally temporary and improve as your eye begins to heal.<\/p>\n
Most patients are able to resume normal daily activities relatively soon after surgery. You may still need to take certain precautions during the initial recovery phase to support proper healing. This helps ensure the best possible outcome for you.<\/p>\n
Follow-up care is still essential after MIGS to monitor your recovery and treatment results. You may notice that healing experiences vary between patients depending on individual factors. Regular check-ups allow your specialist to track progress and adjust your care if needed.<\/p>\n
Long-Term Outcomes<\/h2>\n
Long-term effectiveness of MIGS is an important area of ongoing research in your glaucoma care. You may find that studies suggest MIGS can help reduce intraocular pressure over time, contributing to better disease control in many patients. This makes it a valuable option for selected cases.<\/p>\n
However, you should be aware that results may not be as strong as more invasive surgeries, especially in advanced glaucoma. You may still require additional treatments or ongoing management depending on the severity of your condition. This highlights the importance of careful patient selection.<\/p>\n
Researchers continue to evaluate the durability and long-term success rates of MIGS. You may notice that evidence is still evolving as more long-term data becomes available. Overall, MIGS remains a promising but developing option in modern glaucoma management for you.<\/p>\n
MIGS and Medication Reduction<\/h2>\n
![\"\"](\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/06\/imagess-6-7.jpg\")
<\/p>\nOne of the potential benefits of MIGS is reducing the need for glaucoma medications in your treatment plan. You may find that after surgery, you require fewer eye drops to help control intraocular pressure. This can make your daily eye care routine simpler and more manageable.<\/p>\n
By reducing the number of medications, MIGS may help improve treatment adherence and overall quality of life for you. You may experience less burden from frequent dosing, which can make long-term management easier. However, the extent of medication reduction varies between individuals.<\/p>\n
It is important to understand that not all patients will become completely medication-free after MIGS. You may still need to continue using some eye drops depending on your response to surgery. Outcomes depend on your individual eye condition, disease severity, and healing response.<\/p>\n
Role in Treatment Pathways<\/h2>\n
If you are living with glaucoma, you may notice that treatment approaches are becoming more flexible than before. Minimally invasive glaucoma surgery (MIGS) has introduced an important intermediate option between eye drops and traditional glaucoma surgery. If your condition is not fully controlled with medication alone, MIGS may be considered as a next step before moving on to more complex procedures. This allows your treatment plan to be tailored more closely to your needs.<\/p>\n
- \n
- MIGS Acts as an Intermediate Option for You: <\/strong>If eye drops are not enough to control your eye pressure, MIGS may be offered before major surgery is considered. This gives you an additional treatment step within your care pathway.<\/li>\n
- More Flexible Treatment Planning for You: <\/strong>If your glaucoma changes over time, your treatment can be adjusted more easily. MIGS provides another option that can be integrated into your ongoing management.<\/li>\n
- A Stepwise Approach to Your Care: <\/strong>If you follow a structured treatment pathway, you may move gradually from medication to minimally invasive procedures, and only then to more complex surgery if needed. This helps ensure each step is appropriate for your condition.<\/li>\n
- Treatment Is Becoming More Personalised for You: <\/strong>If your care is tailored to your specific disease severity and response, you are more likely to receive the most suitable treatment at the right time. MIGS supports this individualised approach.<\/li>\n
- Improved Decision-Making in Your Management: <\/strong>If multiple treatment options are available, your specialist can choose the most effective pathway for you. This can lead to better long-term pressure control and outcomes.<\/li>\n<\/ul>\n
MIGS has changed the way glaucoma is managed by adding more flexibility to treatment pathways. If you are undergoing care, you may benefit from a more gradual and personalised approach rather than moving directly to major surgery. Over time, this stepwise strategy can help optimise both safety and effectiveness in your glaucoma management.<\/p>\n
Device Evolution<\/h2>\n
MIGS devices continue to evolve based on ongoing clinical research in your glaucoma care. You may benefit from continuous improvements aimed at enhancing fluid drainage while reducing surgical complications. These developments help make procedures safer and more effective over time.<\/p>\n
New materials and advanced designs are being tested to improve device performance and long-term stability. You may see innovations that allow for more precise control of intraocular pressure and better compatibility with eye tissues. This focus on refinement helps improve overall surgical outcomes for patients like you.<\/p>\n
Innovation remains central to progress in this field of glaucoma treatment. You may find that future devices are designed to offer even greater safety, durability, and effectiveness. Overall, device evolution continues to support better long-term results in MIGS procedures.<\/p>\n
Research into New Techniques<\/h2>\n
Researchers are continuously developing new surgical techniques within MIGS to improve precision and effectiveness in your glaucoma care. You may benefit from these advancements as they aim to make procedures more targeted and efficient. This ongoing innovation helps refine how intraocular pressure is managed during surgery.<\/p>\n
Clinical studies are currently evaluating different procedural combinations to determine the best outcomes. You may see that combining techniques can help optimise pressure reduction in certain patients. These studies are designed to identify the most effective approaches for long-term disease control for you.<\/p>\n
Research in this area is ongoing across multiple clinical centres worldwide. You may find that results from these studies continue to shape how MIGS is performed in the future. Overall, this continuous development supports safer and more effective surgical options for patients like you.<\/p>\n
Comparison with Traditional Surgery<\/h2>\n
Traditional glaucoma surgery remains more effective for advanced disease, especially when significant pressure reduction is required in your care. However, you may find that it carries higher risks and a longer recovery period compared to minimally invasive options. This makes it more suitable for specific, more severe cases.<\/p>\n
MIGS offers a safer alternative for earlier stages of glaucoma, particularly when your condition is mild to moderate. You may benefit from a less invasive procedure with a quicker recovery, although the pressure-lowering effect may be more modest. The choice of treatment depends on your individual disease severity and overall needs.<\/p>\n
Both approaches play important roles in glaucoma management. You may require one or a combination of these options depending on how your condition progresses. Overall, your specialist will determine the most appropriate surgical strategy to achieve the best long-term outcome for you.<\/p>\n
Cost and Accessibility<\/h2>\n
Cost is an important consideration in the adoption of MIGS in your glaucoma care. You may find that pricing varies depending on the type of device used, the procedure, and the healthcare system in which you are treated. These factors can influence how accessible MIGS is for different patients.<\/p>\n
In some regions, MIGS may not yet be widely available due to limited resources or specialised surgical requirements. You may notice that access depends on local clinical expertise and hospital infrastructure. However, the availability of these procedures is gradually increasing worldwide.<\/p>\n
As awareness and technology improve, access to MIGS continues to expand over time. You may benefit from wider availability in the future as more surgeons are trained and more devices become approved. Overall, increasing accessibility is helping more patients receive advanced glaucoma care options.<\/p>\n
Future Research Directions<\/h2>\n
If you are following developments in glaucoma care, you may be interested to know that MIGS continues to evolve quickly. Future research is focused on improving long-term outcomes, making procedures more effective, and understanding which patients benefit most. Scientists are also working on new device technologies that may expand the range of options available to you in the future. If these advances continue, you may see even more refined and personalised surgical choices.<\/p>\n
- \n
- Focus on Better Long-Term Outcomes for You: <\/strong>If MIGS techniques improve further, you may experience more sustained and stable eye pressure control over time. This is a key goal of ongoing research.<\/li>\n
- New Device Technologies Are Being Developed for You: <\/strong>If you are treated in the future, you may benefit from newer MIGS devices designed to be more effective and longer lasting. These innovations aim to improve safety and precision.<\/li>\n
- Combining MIGS With Other Treatments for You: <\/strong>Researchers are exploring whether combining MIGS with medical or laser treatments could improve results. If successful, this may offer you more comprehensive pressure control.<\/li>\n
- Expanding Who Can Benefit From MIGS: <\/strong>If current studies are successful, more patients with different stages of glaucoma may become eligible for MIGS. This could broaden your treatment options.<\/li>\n
- Rapid Progress in the Field for You: <\/strong>If you follow ophthalmology research, you will see that MIGS technology is advancing quickly. This means your future treatment options may continue to improve over time.<\/li>\n<\/ul>\n
Future research in MIGS is aimed at making glaucoma treatment more effective, safer, and more widely applicable. If you are affected by glaucoma, these developments may eventually give you access to more personalised and durable treatment strategies. Over time, ongoing innovation is expected to further improve outcomes and expand the role of minimally invasive surgery in your care pathway.<\/p>\n
Limitations of MIGS<\/h2>\n
Despite its advantages, MIGS has certain limitations in your glaucoma care. You may find that it is not always sufficient for managing advanced stages of glaucoma where a greater reduction in intraocular pressure is required. In such cases, more traditional surgical approaches may still be necessary.<\/p>\n
Some patients may still need additional surgery or continued use of glaucoma medications even after MIGS. You may experience improved pressure control, but complete independence from treatment is not always possible. This depends on how your individual eye responds to the procedure.<\/p>\n
Understanding these limitations is important when planning your treatment. You may benefit from a realistic discussion with your specialist about expected outcomes and long-term needs. Careful evaluation ensures that the most appropriate approach is chosen for your condition.<\/p>\n
Importance of Clinical Evidence<\/h2>\n
Ongoing clinical trials are essential for validating MIGS procedures in your glaucoma care. You may find that these studies help determine the safety, effectiveness, and long-term outcomes of different surgical techniques. This ensures that new approaches are properly assessed before being widely used.<\/p>\n
Evidence-based practice plays a key role in making sure you receive appropriate and reliable care. You may benefit from treatments that are supported by strong clinical data rather than experimental use alone. Research findings continue to shape and refine clinical guidelines over time.<\/p>\n
This growing body of evidence strengthens treatment decision-making for you and your specialist. You may notice that recommendations are regularly updated as new results become available. Overall, clinical evidence helps ensure safer and more effective glaucoma management.<\/p>\n
Seeking Specialist Care<\/h2>\n
![\"\"](\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/06\/imagess-7-8.jpg\")
<\/p>\nIf you are considering surgical options for glaucoma, professional assessment is essential for your treatment planning. You may benefit from a detailed evaluation to determine whether MIGS is appropriate for your specific condition. This helps ensure the safest and most effective approach for your eye health.<\/p>\n
MIGS may be suitable for selected patients depending on the stage of your disease and overall eye health. You may find that it is more appropriate for mild to moderate glaucoma rather than advanced cases. A specialist will assess your suitability based on your individual clinical findings.<\/p>\n
Seeking timely specialist advice is important to protect your vision. You may achieve better long-term outcomes when your treatment is carefully tailored to your needs. Overall, expert evaluation ensures that the most appropriate surgical option is chosen for you.<\/p>\n
FAQs:<\/h2>\n
- \n
- What is MIGS in glaucoma treatment?
\n<\/strong>MIGS stands for Minimally Invasive Glaucoma Surgery, a group of procedures designed to lower intraocular pressure. It is less invasive than traditional glaucoma surgery and focuses on improving fluid drainage in the eye. MIGS is mainly used for patients with mild to moderate glaucoma. It offers a safer and quicker recovery option in many cases.<\/li>\n- How does MIGS work?
\n<\/strong>MIGS works by enhancing the natural outflow of fluid from the eye, which helps reduce intraocular pressure. Different techniques target different drainage pathways depending on the procedure used. By lowering pressure, it helps protect the optic nerve from damage. The goal is to slow or prevent progression of glaucoma.<\/li>\n- Who is suitable for MIGS surgery?
\n<\/strong>MIGS is generally suitable for patients with early to moderate glaucoma. A detailed eye assessment is required to determine if it is appropriate. Factors such as disease severity and eye structure are carefully considered. It is usually not recommended for advanced glaucoma cases.<\/li>\n- Is MIGS safer than traditional glaucoma surgery?
\n<\/strong>Yes, MIGS is considered safer because it is less invasive and involves fewer complications. It typically has a lower risk profile compared to traditional glaucoma surgery. However, all surgical procedures carry some risks, including inflammation or temporary pressure changes. Overall, it is designed to improve safety and recovery.<\/li>\n- How long does recovery take after MIGS?
\n<\/strong>Recovery after MIGS is usually quicker than traditional surgery. Most patients experience mild discomfort for a short period after the procedure. Many can return to normal activities fairly soon, depending on individual healing. Regular follow-up appointments are still important.<\/li>\n- Can MIGS reduce the need for eye drops?
\n<\/strong>Yes, MIGS can reduce the number of eye drops needed in some patients. It helps lower eye pressure more consistently, which may reduce medication dependence. However, not all patients become completely free of drops. The outcome depends on individual response to surgery.<\/li>\n- Is MIGS performed with cataract surgery?
\n<\/strong>MIGS is often performed alongside cataract surgery in many patients. This combined approach allows both vision improvement and pressure reduction in a single procedure. It also helps streamline recovery time. It is a commonly used treatment strategy in clinical practice.<\/li>\n- How effective is MIGS in the long term?
\n<\/strong>MIGS can provide sustained reduction in intraocular pressure over time. However, its effectiveness may be less than traditional surgery in advanced glaucoma. Long-term results are still being studied in clinical research. Outcomes can vary depending on the patient.<\/li>\n- What are the risks of MIGS surgery?
\n<\/strong>MIGS is generally safe, but it does have some risks like any surgery. These may include temporary inflammation, mild discomfort, or pressure fluctuations. Serious complications are rare compared to traditional surgery. A specialist will explain all risks before the procedure.<\/li>\n- When should MIGS be considered for glaucoma?
\n<\/strong>MIGS is usually considered when eye drops are not enough to control intraocular pressure. It is often recommended in early to moderate stages of glaucoma. A specialist evaluation helps decide the best timing and suitability. It is part of a step-by-step treatment approach.<\/li>\n<\/ol>\nFinal Thought: Advancing MIGS and Your Glaucoma Care Journey<\/h2>\n
MIGS is changing the way you can think about glaucoma treatment, offering a safer and less invasive surgical option that can help lower eye pressure with quicker recovery times. While it may not be suitable for every stage of glaucoma, ongoing research and improved techniques are making it an increasingly valuable option in modern care. As these innovations continue to develop, you can expect more personalised and effective treatment pathways in the future.<\/p>\n
If you\u2019re considering glaucoma treatment in London<\/a> and want to know if it\u2019s the right option, you\u2019re welcome to reach out to us at Eye Clinic London to book a consultation.<\/p>\n
References:<\/h2>\n
- \n
- Saheb, H. and Ahmed, I.I.K. (2012) \u2018Micro-invasive glaucoma surgery: Current perspectives and future directions\u2019, Current Opinion in Ophthalmology, 23(2), pp. 96\u2013104. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/22249233\/<\/a><\/li>\n
- Balas, M. and Mathew, D.J. (2023) \u2018Minimally Invasive Glaucoma Surgery: A Review of the Literature\u2019, Vision, 7(3), p. 54. Available at: https:\/\/www.mdpi.com\/2411-5150\/7\/3\/54<\/a><\/li>\n
- Dhawale, K.K., et al. (2024) \u2018A Comprehensive Review of Recent Advances in Minimally Invasive Glaucoma Surgery\u2019, Cureus, 16(7), e65539. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11342062\/<\/a><\/li>\n
- Richter, G.M. and Coleman, A.L. (2016) \u2018Minimally invasive glaucoma surgery: Current status and future prospects\u2019, Clinical Ophthalmology, 10, pp. 189\u2013206. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4734795\/<\/a><\/li>\n
- Cheema, A.A. and Cheema, H.R. (2024) \u2018The Evolution and Current Landscape of Minimally Invasive Glaucoma Surgeries: A Review\u2019, Cureus, 16(1), e52183. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/38264176\/<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"
Minimally invasive glaucoma surgery, commonly known as MIGS, has become an important development in modern glaucoma care. You may be offered this less invasive option as an alternative to traditional glaucoma surgery, with the aim of lowering intraocular pressure and slowing disease progression. It is designed to provide effective treatment while reducing surgical trauma for you. In recent years, MIGS procedures have evolved rapidly with improved devices, refined techniques, and better patient selection criteria. You may benefit from these advancements<\/p>\n","protected":false},"author":33,"featured_media":17132,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-17698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\n
Latest Research on MIGS for Glaucoma<\/title>\n<meta name=\"description\" content=\"Explore the latest research and advances in minimally invasive glaucoma surgery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Research on Minimally Invasive Glaucoma Surgery (MIGS)\" \/>\n<meta property=\"og:description\" content=\"Explore the latest research and advances in minimally invasive glaucoma surgery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Samer Hamada | Eye Clinic London\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-29T07:52:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1100\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eye Clinic London\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eye Clinic London\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"20 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/\"},\"author\":{\"name\":\"Eye Clinic London\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/person\/44a356218e856152b4fceafe46f1d5c8\"},\"headline\":\"New Research on Minimally Invasive Glaucoma Surgery (MIGS)\",\"datePublished\":\"2026-06-29T07:52:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/\"},\"wordCount\":4354,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/\",\"url\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/\",\"name\":\"Latest Research on MIGS for Glaucoma\",\"isPartOf\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg\",\"datePublished\":\"2026-06-29T07:52:12+00:00\",\"description\":\"Explore the latest research and advances in minimally invasive glaucoma surgery.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage\",\"url\":\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg\",\"contentUrl\":\"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg\",\"width\":1100,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.eyecliniclondon.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Research on Minimally Invasive Glaucoma Surgery (MIGS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#website\",\"url\":\"https:\/\/www.eyecliniclondon.com\/blog\/\",\"name\":\"Samer Hamada | Eye Clinic London\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.eyecliniclondon.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#organization\",\"name\":\"Eye Clinic London\",\"url\":\"https:\/\/www.eyecliniclondon.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/eyecliniclondon.com\/wp-content\/uploads\/2019\/10\/Eye-clinic-london-logo-240.png\",\"contentUrl\":\"https:\/\/eyecliniclondon.com\/wp-content\/uploads\/2019\/10\/Eye-clinic-london-logo-240.png\",\"width\":240,\"height\":60,\"caption\":\"Eye Clinic London\"},\"image\":{\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/person\/44a356218e856152b4fceafe46f1d5c8\",\"name\":\"Eye Clinic London\",\"sameAs\":[\"https:\/\/www.eyecliniclondon.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Latest Research on MIGS for Glaucoma","description":"Explore the latest research and advances in minimally invasive glaucoma surgery.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/","og_locale":"en_GB","og_type":"article","og_title":"New Research on Minimally Invasive Glaucoma Surgery (MIGS)","og_description":"Explore the latest research and advances in minimally invasive glaucoma surgery.","og_url":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/","og_site_name":"Samer Hamada | Eye Clinic London","article_published_time":"2026-06-29T07:52:12+00:00","og_image":[{"width":1100,"height":600,"url":"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg","type":"image\/jpeg"}],"author":"Eye Clinic London","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Eye Clinic London","Estimated reading time":"20 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#article","isPartOf":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/"},"author":{"name":"Eye Clinic London","@id":"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/person\/44a356218e856152b4fceafe46f1d5c8"},"headline":"New Research on Minimally Invasive Glaucoma Surgery (MIGS)","datePublished":"2026-06-29T07:52:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/"},"wordCount":4354,"commentCount":0,"publisher":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg","articleSection":["Uncategorized"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/","url":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/","name":"Latest Research on MIGS for Glaucoma","isPartOf":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage"},"image":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg","datePublished":"2026-06-29T07:52:12+00:00","description":"Explore the latest research and advances in minimally invasive glaucoma surgery.","breadcrumb":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#primaryimage","url":"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg","contentUrl":"https:\/\/www.eyecliniclondon.com\/blog\/wp-content\/uploads\/2026\/05\/1-8.jpg","width":1100,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.eyecliniclondon.com\/blog\/migs-glaucoma-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eyecliniclondon.com\/blog\/"},{"@type":"ListItem","position":2,"name":"New Research on Minimally Invasive Glaucoma Surgery (MIGS)"}]},{"@type":"WebSite","@id":"https:\/\/www.eyecliniclondon.com\/blog\/#website","url":"https:\/\/www.eyecliniclondon.com\/blog\/","name":"Samer Hamada | Eye Clinic London","description":"","publisher":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eyecliniclondon.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.eyecliniclondon.com\/blog\/#organization","name":"Eye Clinic London","url":"https:\/\/www.eyecliniclondon.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/eyecliniclondon.com\/wp-content\/uploads\/2019\/10\/Eye-clinic-london-logo-240.png","contentUrl":"https:\/\/eyecliniclondon.com\/wp-content\/uploads\/2019\/10\/Eye-clinic-london-logo-240.png","width":240,"height":60,"caption":"Eye Clinic London"},"image":{"@id":"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.eyecliniclondon.com\/blog\/#\/schema\/person\/44a356218e856152b4fceafe46f1d5c8","name":"Eye Clinic London","sameAs":["https:\/\/www.eyecliniclondon.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/posts\/17698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/comments?post=17698"}],"version-history":[{"count":0,"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/posts\/17698\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/media\/17132"}],"wp:attachment":[{"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/media?parent=17698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/categories?post=17698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eyecliniclondon.com\/blog\/wp-json\/wp\/v2\/tags?post=17698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} - Balas, M. and Mathew, D.J. (2023) \u2018Minimally Invasive Glaucoma Surgery: A Review of the Literature\u2019, Vision, 7(3), p. 54. Available at: https:\/\/www.mdpi.com\/2411-5150\/7\/3\/54<\/a><\/li>\n
- How does MIGS work?
- New Device Technologies Are Being Developed for You: <\/strong>If you are treated in the future, you may benefit from newer MIGS devices designed to be more effective and longer lasting. These innovations aim to improve safety and precision.<\/li>\n
- More Flexible Treatment Planning for You: <\/strong>If your glaucoma changes over time, your treatment can be adjusted more easily. MIGS provides another option that can be integrated into your ongoing management.<\/li>\n
- Disease Severity Matters for Your Treatment: <\/strong>If your glaucoma is in the early to moderate stages, you may be more likely to benefit from MIGS. More advanced disease may require different surgical approaches.<\/li>\n